You are here

Arterial-Venous Eye Pulse Oximeter (AVEPOX)

Award Information
Agency: Department of Defense
Branch: Army
Contract: DAMD17-03-C-001
Agency Tracking Number: A022-1434
Amount: $119,996.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 2003
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
20600 Gramercy Place, Bldg. 100
Torrance, CA 90501
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Paul Schnitser
 Vice President
 (310) 320-7892
 poc@social.rr.com
Business Contact
 Gordon Drew
Title: Chief Financial Officer
Phone: (310) 320-3088
Email: gdrew@poc.com
Research Institution
N/A
Abstract

Hemorrhage is the primary cause of death on the battlefield. Army has a pressing need for a non-invasive device that can measure vital organ arterial and venous blood oxygen saturation to assess whether, and when, oxygen delivery and absorption isadequate. To meet this need Physical Optics Corporation (POC) proposes to develop a new Arterial-Venous Eye Pulse Oximeter (AVEPOX). AVEPOX will operate with a spatially modulated, multiwavelength, laser light. Packaged as a hand-held ophthalmoscope, itwill allow separate, non-invasive, on?battlefield measurement of oxygen saturation of both arterial and venous blood and save in its memory or immediately transmit this information to a medical center. In Phase I, POC will develop a laboratory model andthen test it using an optical model of human eye and on chicken embryo. In Phase II, a full-scale hand?held prototype will be fabricated and tested on small animal models. The proposed AVEPOX will become a state-of-the-art non-invasive optical oximetrydevice allowing simultaneous and independent measurement of arterial and venous blood oxygen saturation. This instrument will profoundly improve the diagnostics and treatment of numerous hypoxia-related diseases such as hemorrhage injures, diabetes,ulcers, and cardiovascular disorders.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government